| View |
|
DRP-9054-01
|
Cefotaxime (as sodium)
|
Tergen
|
1 g
|
Powder for Injection (IM/IV)
|
Antibacterial (Third-Generation Cephalosporin)
|
NCPC Hebei Huamin Pharmaceutical Company Limited
|
China
|
CLIDP Conversion
|
13 July 2022
|
31 October 2025
|
| View |
|
DRP-10961-02
|
Ceftriaxone (as sodium)
|
CEFTRIOVINN
|
1g
|
Powder for Injection
|
Antibacterial (Third-generation Cephalosporin)
|
Furen Pharmaceutical Group Co., Ltd.
|
China
|
CLIDP Conversion
|
12 July 2022
|
22 December 2026
|
| View |
|
DR-XY37556
|
Glimepiride
|
Norizec
|
2mg
|
Tablet
|
Sulfonylurea
|
Amherst Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
08 July 2022
|
09 July 2027
|
| View |
|
DRP-11547-01
|
Paracetamol
|
Paracent
|
10 mg / mL ( 1g / 100 mL)
|
Solution for Injection (IV Infusion)
|
Analgesic / Anti-pyretic (Anilide)
|
Genuone Sciences Inc.
|
Korea
|
CLIDP Conversion
|
08 July 2022
|
30 March 2027
|
| View |
|
DRP-5930-03
|
Omeprazole Sodium
|
Ovint
|
40 mg
|
Lyophilized Powder for Injection
|
Proton Pump Inhibitor
|
FUREN PHARMACEUTICAL GROUP CO., LTD
|
China
|
Renewal
|
13 September 2023
|
05 December 2028
|
| View |
|
DRP-11801-02
|
Cefuroxime (as Sodium)
|
Gemicef
|
750mg
|
Powder for Injection (I.M./I.V.)
|
Antibacterial (Cephalosporin)
|
Furen Pharmaceutical Group Co., Ltd.
|
China
|
CLIDP Conversion
|
08 July 2022
|
29 April 2027
|
| View |
|
DRP-8930-01
|
CARBOPLATIN
|
CARBOXEL-450
|
10mg/ml (450mg/45ml)
|
Solution for Injection (IV Infusion)
|
Antineoplastic (Anthracycline)
|
Intas Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
08 July 2022
|
29 July 2025
|
| View |
|
DRP-6176-01
|
Telmisartan
|
Telstar 40
|
40 mg
|
Tablet
|
Angiotensin II Receptor Blocker
|
Hizon Laboratories, Inc
|
Philippines
|
Renewal
|
23 September 2024
|
23 January 2030
|
| View |
|
DRP-6742-01
|
Telmisartan
|
Telstar 80
|
80 mg
|
Tablet
|
Angiotensin II Receptor Blocker
|
Hizon Laboratories, Inc.
|
Philippines
|
Renewal
|
10 October 2024
|
23 March 2030
|
| View |
|
DRP-11885-01
|
Hydroxyzine Hydrochloride
|
Ziltem
|
25 mg
|
Tablet
|
Antihistamine
|
N/A
|
N/A
|
Automatic Renewal
|
19 July 2023
|
27 September 2028
|
| View |
|
DR-XY41250
|
Candesartan Cilexetil
|
Torcand-8
|
8 mg
|
Tablet
|
ANTIHYPERTENSIVE (ANGIOTENSIN II RECEPTOR BLOCKER)
|
Torrent Pharmaceuticals Limited
|
India
|
Automatic Renewal
|
08 July 2022
|
19 September 2027
|
| View |
|
DRP-12277
|
Moxifloxacin Hydrochloride
|
Ocumox
|
5mg/mL
|
Sterile Ophthalmic Solution
|
Antibacterials (Fluoroquinoles)
|
Remington Pharmaceutical industries (Pvt.) Ltd.
|
Pakistan
|
Renewal
|
29 February 2024
|
11 October 2028
|
| View |
|
DRP-12264
|
Tobramycin
|
Nebra
|
3mg/mL (0.3%)
|
Sterile Ophthalmic Solution
|
-
|
Remington Pharmaceutical industries (Pvt.) Ltd.
|
Pakistan
|
PCPR Conversion
|
08 July 2022
|
16 June 2026
|
| View |
|
DRP-12265
|
Nepafenac
|
Nepanac
|
1mg/mL (0.1% w/v)
|
Sterile Ophthalmic Suspension
|
-
|
Remington Pharmaceutical industries (Pvt.) Ltd
|
Pakistan
|
PCPR Conversion
|
08 July 2022
|
23 June 2026
|
| View |
|
DRP-5881-03
|
Esomeprazole (As Sodium)
|
Nuloc
|
40mg
|
Lyophilized Powder For IV Injection
|
Proton Pump Inhibitor
|
Gufic Biosciences Limited
|
India
|
Automatic Renewal
|
08 July 2022
|
09 December 2027
|
| View |
|
DRP-5881-04
|
Esomeprazole (as sodium)
|
Esodime IV
|
40 mg
|
Lyophilized Powder for IV Injection
|
Proton Pump Inhibitor
|
Gufic Biosciences Limited
|
India
|
Renewal
|
08 July 2022
|
09 December 2027
|
| View |
|
DRP-9866-01
|
Venlafaxine (as hydrochloride)
|
Afaxor 150
|
150 mg
|
Sustained Release Capsule
|
Antidepressant
|
Pell Tech Health Care Pvt. Ltd.
|
India
|
Renewal
|
08 July 2022
|
08 May 2027
|
| View |
|
DRP-12255
|
Prednisolone (as acetate)
|
Fortipred
|
10mg/mL
|
Sterile Ophthalmic Suspension
|
Corticosteroid
|
Remington Pharmaceutical (Pvt.) Ltd
|
Pakistan
|
Renewal
|
02 April 2024
|
03 April 2029
|
| View |
|
DRP-12259
|
Hydroxypropyl Methylcellulose
|
Hicel
|
5mg/mL
|
Ophthalmic Solution
|
Ophthalmic Lubricant
|
Remington Pharmaceutical industries (Pvt.) Ltd.
|
Pakistan
|
Renewal
|
18 March 2024
|
09 May 2029
|
| View |
|
DRP-12249
|
Olopatadine (as hydrochloride)
|
Zolopat Forte
|
2mg/mL
|
Ophthalmic Solution (Eye Drops)
|
Antihistamine
|
Remington Pharmaceuticals Industries (Pvt/) Ltd.
|
Pakistan
|
Renewal
|
25 August 2024
|
13 March 2030
|